vTv Therapeutics Inc
NASDAQ:VTVT

Watchlist Manager
vTv Therapeutics Inc Logo
vTv Therapeutics Inc
NASDAQ:VTVT
Watchlist
Price: 13.91 USD 7.58% Market Closed
Market Cap: 41.9m USD
Have any thoughts about
vTv Therapeutics Inc?
Write Note

P/FCFE
Price to FCFE

-1.9
Current
-151.6
Median
27.3
Industry
Higher than median
Lower than industry value

Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

P/FCFE
-1.9
=
Market Cap
41.9m USD
/
FCFE
-21.8m USD
All Countries
Close
Market Cap P/FCFE
US
vTv Therapeutics Inc
NASDAQ:VTVT
41.9m USD -1.9
FR
Pharnext SCA
OTC:PNEXF
6T USD -3 167 877.8
US
Abbvie Inc
NYSE:ABBV
302.3B USD 12.1
US
Amgen Inc
NASDAQ:AMGN
160.6B USD 27.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.3B USD -90.3
US
Gilead Sciences Inc
NASDAQ:GILD
118.3B USD 11.7
US
Epizyme Inc
F:EPE
94.1B EUR -433.2
AU
CSL Ltd
ASX:CSL
138.5B AUD 82.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
90.4B USD 27.2
US
Seagen Inc
F:SGT
39.3B EUR -59.6
NL
argenx SE
XBRU:ARGX
33.4B EUR -107.1
 
US
vTv Therapeutics Inc
NASDAQ:VTVT
Average P/FCFE: 32.1
Negative Multiple: -1.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -3 167 877.8
US
Abbvie Inc
NYSE:ABBV
12.1
US
Amgen Inc
NASDAQ:AMGN
27.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -90.3
US
Gilead Sciences Inc
NASDAQ:GILD
11.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -433.2
AU
CSL Ltd
ASX:CSL
82.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
27.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.6
NL
argenx SE
XBRU:ARGX
Negative Multiple: -107.1

P/FCFE Forward Multiples

Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/FCFE
N/A
2-Years Forward
P/FCFE
N/A
3-Years Forward
P/FCFE
N/A

See Also

Discover More